2026 Summer Intern – Sales, Gastroenterology at Acadia Pharmaceuticals

Parsippany, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical SalesIndustries

Requirements

Currently pursuing a Bachelor's or Master’s degree in Business, Marketing, Life Sciences, Public Health, or a related field with interest in health care
Strong verbal and written communication skills
Highly organized with attention to detail and ability to manage multiple tasks
Proficiency in Microsoft Excel, PowerPoint, and Outlook; experience with data visualization tools (e.g., Tableau, Power BI) is a plus
Comfortable making outbound calls and engaging with healthcare professionals
Analytical mindset with the ability to interpret data and generate actionable insights
Self-starter with a collaborative spirit and eagerness to learn
Prior internship or work experience in healthcare, sales, or marketing preferred but not required
Preferred geographic location: TX, FL, or NY/NJ/PA
Willing to travel up to 50% each week
Must have a valid driver’s license, have access to and be able to operate a vehicle
Willing and available to travel to the Parsippany, NJ office 2 or 3 times during the 10-week program
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline)
Currently enrolled in an accredited U.S. based college or university

Responsibilities

Sample Management: Review and process sample requests; Track sample usage and follow up with healthcare providers (HCPs) for feedback; Assist in cleaning up open AOCs to optimize field team interactions
Non-Targeted Account Outreach: Contact non-targeted GI practices to introduce a gastro product; Share digital resources and educational materials; Capture interest and route potential leads to the field team; Support outreach to white space accounts to generate new leads
Virtual Support for Targeted Accounts: Schedule and coordinate virtual meetings for the field team; Send follow-up materials post-engagement; Monitor engagement metrics and report insights
Data Analysis & Insights: Analyze territory-level sales data to identify growth opportunities; Create dashboards or reports to track sample utilization and account activity; Support ad hoc analytics requests to inform targeting strategy
Special Projects: Miscellaneous projects based on your strengths and interests

Skills

Sales

Brand Strategy

Marketing

Customer Interactions

Analytics

Sample Management

Healthcare Providers

Account Outreach

Lead Generation

Gastroenterology

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free